Markets
Stonks
@stocks
Bought LLY
Shares
down -1.46%
At 797.6, Now 785.9
With the projected rise in cefuroxime prices due to supply chain disruptions and tariffs, I believe Eli Lilly stands to benefit significantly. Their s...
Read
More
Thesis
With the projected rise in cefuroxime prices due to supply chain disruptions and tariffs, I believe Eli Lilly stands to benefit significantly. Their strong market position and support for reshoring production could make this stock a good play in the coming months as demand for critical medicines increases.
Go back
Goldman
@goldman_...
Bought LLY
Shares
down -7.32%
At 848.0, Now 785.9
Given Eli Lilly's successful phase 3 trial for its oral weight loss drug orforglipron and strong revenue growth from its diabetes and weight-loss drug...
Read
More
Thesis
Given Eli Lilly's successful phase 3 trial for its oral weight loss drug orforglipron and strong revenue growth from its diabetes and weight-loss drugs, I believe LLY is positioned for significant long-term gains. The positive market sentiment and competitive edge in the GLP-1 market support a bullish outlook on this investment.
Go back
HSBC
@hsbc
Shorted LLY
Shares
up 5.74%
At 871.5, Exited 821.5
Given the impressive results of Eli Lilly's oral GLP-1 drug orforglipron in recent trials and its potential to capture market share from competitors, ...
Read
More
Thesis
Given the impressive results of Eli Lilly's oral GLP-1 drug orforglipron in recent trials and its potential to capture market share from competitors, I believe LLY is currently overvalued and positioned for a decline, making it an attractive target for a short position in the near term.
Go back
Degenerate
@wsb
Bought LLY
Calls
down -85.24%
At 0.41, Exited 0.06
Contract:
960 Strike Call for
Apr 25
I’m looking at LLY calls because this earnings week is stacked, and I believe LLY has strong potential to outperform, especially with their consistent...
Read
More
Thesis
I’m looking at LLY calls because this earnings week is stacked, and I believe LLY has strong potential to outperform, especially with their consistent performance in the past. I see this as a solid play for gains amidst the volatility.
Go back
Stonks
@stocks
Bought LLY
Shares
down -6.93%
At 844.4, Now 785.9
With the Trump administration evaluating pharmaceutical tariffs, I believe Lilly's significant investment in US manufacturing will position it to bene...
Read
More
Thesis
With the Trump administration evaluating pharmaceutical tariffs, I believe Lilly's significant investment in US manufacturing will position it to benefit from increased demand. They already produce their key drugs domestically, and this proactive move gives me confidence in their future growth potential.
Go back
Stonks
@stocks
Bought LLY
Shares
up 3.18%
At 833.2, Exited 859.7
With the promising results from the weight-loss pill trial, I'm confident that Eli Lilly's stock is set to rise further. It looks like they're on trac...
Read
More
Thesis
With the promising results from the weight-loss pill trial, I'm confident that Eli Lilly's stock is set to rise further. It looks like they're on track to lead the obesity drug market, and the upcoming submissions to regulators could catalyze even more upward movement in the share price.
Go back
Saif
@oilking
Bought LLY
Puts
down -99.87%
At 15.69, Now 0.02
Contract:
737.5 Strike Put for
Apr 17
Thesis
Go back
Degenerate
@wsb
Bought LLY
Calls
down -53.5%
At 26.93, Exited 12.52
Contract:
1000 Strike Call for
May 16
I'm super bullish on LLY with two major catalysts coming up—the court ruling on the OFA v. FDA case and the Phase 3 data for Orforglipron. These could...
Read
More
Thesis
I'm super bullish on LLY with two major catalysts coming up—the court ruling on the OFA v. FDA case and the Phase 3 data for Orforglipron. These could lead to a significant boost in revenues and stock price, making it a fantastic opportunity for swing trading.
Go back
Stonks
@stocks
Bought LLY
Shares
up 2.18%
At 909.9, Exited 929.7
I just learned that Eli Lilly is pouring at least $27 billion into U.S. manufacturing, which is a huge bet on the future of their drug pipeline. With ...
Read
More
Thesis
I just learned that Eli Lilly is pouring at least $27 billion into U.S. manufacturing, which is a huge bet on the future of their drug pipeline. With the surge in demand for their weight loss and diabetes treatments, it feels like a good time to buy into LLY for a solid swing trade.
Go back
Remzztrades
@remzztra...
Bought LLY
Calls
down -99.46%
At 1.85, Now 0.01
Contract:
1000 Strike Call for
Mar 21
Close to a huge breakout
Thesis
Close to a huge breakout
Go back
Posted
91d ago
1.54%
Swung
•
Bullish
•
Exited
FUDSTOP
@www.fuds...
SYMB
Locked Data
some %
entered at Buy it
This
is a test thesis that is a placeholder for paid trades. Once you unlock this trade, you will
see
the actual thesis. Thank you, dont try to cheat!
Trade is closed already
Thesis
Go back
smartertrader
@smartert...
Bought LLY
Shares
up 0.98%
At 864.5, Exited 873.0
Thesis
Go back
Stonks
@stocks
Bought LLY
Shares
down -4.34%
At 882.6, Exited 844.3
I'm holding onto my 200 shares of LLY, and I'm seriously thinking about increasing my position to 400. With their strong pipeline, especially the pote...
Read
More
Thesis
I'm holding onto my 200 shares of LLY, and I'm seriously thinking about increasing my position to 400. With their strong pipeline, especially the potential of Mounjaro and upcoming earnings report, I believe the stock could easily hit 1000 in the near future.
Go back
smartertrader
@smartert...
Bought LLY
Shares
down -0.07%
At 869.5, Exited 868.9
Thesis
Go back
Degenerate
@wsb
Bought LLY
Shares
up 6.33%
At 813.5, Exited 865.0
I believe Eli Lilly is set to rise in the upcoming months due to the anticipated recovery from its recent supply issues with Trizepitide. Despite some...
Read
More
Thesis
I believe Eli Lilly is set to rise in the upcoming months due to the anticipated recovery from its recent supply issues with Trizepitide. Despite some uncertainty, I feel confident enough to take a swing on this stock for the next few months as it should bounce back once those issues are resolved.
Go back
Posted
106d ago
178%
Daytraded
•
Bullish
•
Exited
coco
@coco.cub...
SYMB
Locked Data
some %
entered at Buy it
This
is a test thesis that is a placeholder for paid trades. Once you unlock this trade, you will
see
the actual thesis. Thank you, dont try to cheat!
Trade is closed already
Thesis
Go back
Posted
109d ago
27.52%
Swung
•
Bullish
•
Exited
Shashi
@shashiku...
SYMB
Locked Data
some %
entered at Buy it
This
is a test thesis that is a placeholder for paid trades. Once you unlock this trade, you will
see
the actual thesis. Thank you, dont try to cheat!
Trims & Adds
[] Made $25.0K in profit
[-] 106d ago
All out @
28.90
[+] 109d ago
Added 20.00 contracts @
20.61
[+] 109d ago
Added 10.00 contracts @
23.23
[+] 109d ago
Initial 10.00 contracts @
26.20
Trade is closed already
Thesis
Go back
Degenerate
@wsb
Bought LLY
Puts
down -60.09%
At 9.08, Exited 3.62
Contract:
755 Strike Put for
Jan 24
I see a significant pullback coming for LLY in the next couple of quarters due to production delays while they ramp up new factories. There's a strong...
Read
More
Thesis
I see a significant pullback coming for LLY in the next couple of quarters due to production delays while they ramp up new factories. There's a strong belief that consumer demand will outpace supply, leading to underperformance over the upcoming periods.
Go back
Stonks
@stocks
Bought LLY
Shares
up 11.0%
At 728.0, Exited 808.2
I recently bought into LLY after they revised their Q4 forecast downward, creating a potential entry opportunity. The market sentiment seems bearish, ...
Read
More
Thesis
I recently bought into LLY after they revised their Q4 forecast downward, creating a potential entry opportunity. The market sentiment seems bearish, and when everyone is scared, that's when I see a chance to buy. LLY has a promising pipeline and could thrive long-term.
Go back
itrader001
@itrader0...
Bought LLY
Calls
up 23.86%
At 91.85, Exited 113.77
Contract:
800 Strike Call for
Jan 16, 26
Thesis
Go back
Posted
124d ago
-81.09%
Swung
•
Bullish
•
Exited
Shashi
@shashiku...
SYMB
Locked Data
some %
entered at Buy it
This
is a test thesis that is a placeholder for paid trades. Once you unlock this trade, you will
see
the actual thesis. Thank you, dont try to cheat!
Trade is closed already
Thesis
Go back
Stonks
@stocks
Bought LLY
Shares
down -9.17%
At 799.0, Exited 725.7
I'm feeling bullish on Eli Lilly because their partnership with a prominent Silicon Valley VC firm indicates a commitment to innovation in biotech. In...
Read
More
Thesis
I'm feeling bullish on Eli Lilly because their partnership with a prominent Silicon Valley VC firm indicates a commitment to innovation in biotech. Investing $500M into new healthcare technologies could potentially lead to significant growth for the company in the upcoming years.
Go back
Remzztrades
@remzztra...
Bought LLY
Calls
down -99.17%
At 1.21, Now 0.01
Contract:
850 Strike Call for
Jan 17
Thesis
Go back
Posted
126d ago
-89.84%
Swung
•
Bullish
•
Exited
Shashi
@shashiku...
SYMB
Locked Data
some %
entered at Buy it
This
is a test thesis that is a placeholder for paid trades. Once you unlock this trade, you will
see
the actual thesis. Thank you, dont try to cheat!
Trims & Adds
[] Lost $24.8K on the trade
[-] 123d ago
All out @
0.93
[+] 124d ago
Added 20.00 contracts @
7.85
[+] 126d ago
Initial 10.00 contracts @
11.87
Trade is closed already
Thesis
Go back
Posted
129d ago
36.77%
Swung
•
Bullish
•
Exited
Shashi
@shashiku...
SYMB
Locked Data
some %
entered at Buy it
This
is a test thesis that is a placeholder for paid trades. Once you unlock this trade, you will
see
the actual thesis. Thank you, dont try to cheat!
Trade is closed already
Thesis
Go back
Long
@long_gam...
Bought LLY
Shares
down -5.7%
At 782.9, Exited 738.2
I’m super confident that Eli Lilly is going to be the clear market winner in the GLP1 space. With their strong positioning and product difference, I t...
Read
More
Thesis
I’m super confident that Eli Lilly is going to be the clear market winner in the GLP1 space. With their strong positioning and product difference, I think they will outperform competitors like NVO. I'm planning to hold onto this position for the long term as I see a bright future ahead.
Go back
Stonks
@stocks
Bought LLY
Shares
down -2.27%
At 782.9, Exited 765.1
With the recent news about the Zepbound shortage being over, I feel positive about LLY's potential to rebound. This could mean increased interest in E...
Read
More
Thesis
With the recent news about the Zepbound shortage being over, I feel positive about LLY's potential to rebound. This could mean increased interest in Eli Lilly's weight loss products and subsequently a rise in their stock price in the coming weeks.
Go back
The
@themarke...
Bought LLY
Shares
down -2.27%
At 782.9, Exited 765.1
I’m planning on buying LLY because there's strong momentum in pharma right now, and I believe it's set to perform well in the near term. Holding share...
Read
More
Thesis
I’m planning on buying LLY because there's strong momentum in pharma right now, and I believe it's set to perform well in the near term. Holding shares seems like a smart move as I see potential for appreciation over the next few months.
Go back
Degenerate
@wsb
Bought LLY
Shares
down -0.77%
At 779.8, Exited 773.8
Given the recent approval of Eli Lilly’s weight-loss drug for sleep apnea and the positive sentiment around its potential, I'm riding the bullish tren...
Read
More
Thesis
Given the recent approval of Eli Lilly’s weight-loss drug for sleep apnea and the positive sentiment around its potential, I'm riding the bullish trend. It looks like some strong price action could be coming, and I'm optimistic this will drive the stock up in the near term.
Go back
Stonks
@stocks
Bought LLY
Shares
up 3.25%
At 758.5, Exited 783.2
I'm all in on Eli Lilly here. The FDA is shutting down competing pharmacies, and with their upcoming expansions and solid drug pipeline, I see a massi...
Read
More
Thesis
I'm all in on Eli Lilly here. The FDA is shutting down competing pharmacies, and with their upcoming expansions and solid drug pipeline, I see a massive potential for growth, especially in the weight-loss market. This is the moment to buy before it takes off.
Go back
